The article presents the earnings overview for Bristol-Myers Squibb Co. (BMY):
For the first quarter, the company reported a loss of $11.91 billion compared to earnings of $2.26 billion for the same period in the previous year. The earnings per share (EPS) stands at -$5.89 in the first quarter compared to $1.07 over the same timeframe last year. Once exceptional items are excluded, Bristol-Myers Squibb Co. reveals adjusted loss of approximately $8.91 billion or -$4.40 per share for the quarter.
Analysts had predicted an EPS of -$4.44. The revenue for the first quarter amounted to $11.87 billion as compared to $11.34 billion during the same period in the previous year.
As for the year's EPS guidance, it ranges between $0.40 and $0.70.
